TERT promoter mutations and telomerase reactivation in urothelial cancer S Borah, L Xi, AJ Zaug, NM Powell, GM Dancik, SB Cohen, JC Costello, ... Science 347 (6225), 1006-1010, 2015 | 351 | 2015 |
A 20-gene model for molecular nodal staging of bladder cancer: development and prospective assessment SC Smith, AS Baras, G Dancik, Y Ru, KF Ding, CA Moskaluk, Y Fradet, ... The lancet oncology 12 (2), 137-143, 2011 | 166 | 2011 |
Concurrent alterations in TERT, KDM6A, and the BRCA pathway in bladder cancer ML Nickerson, GM Dancik, KM Im, MG Edwards, S Turan, J Brown, ... Clinical Cancer Research 20 (18), 4935-4948, 2014 | 130 | 2014 |
Inhibition of the CCL2 receptor, CCR2, enhances tumor response to immune checkpoint therapy MM Tu, HA Abdel-Hafiz, RT Jones, A Jean, KJ Hoff, JE Duex, ... Communications Biology 3 (1), 720, 2020 | 128 | 2020 |
mlegp: statistical analysis for computer models of biological systems using R GM Dancik, KS Dorman Bioinformatics 24 (17), 1966-1967, 2008 | 111* | 2008 |
shinyGEO: a web-based application for analyzing gene expression omnibus datasets J Dumas, MA Gargano, GM Dancik Bioinformatics 32 (23), 3679-3681, 2016 | 82 | 2016 |
An osteopontin/CD44 axis in RhoGDI2-mediated metastasis suppression M Ahmed, JL Sottnik, GM Dancik, D Sahu, DE Hansel, D Theodorescu, ... Cancer cell 30 (3), 432-443, 2016 | 81 | 2016 |
Role in tumor growth of a glycogen debranching enzyme lost in glycogen storage disease S Guin, C Pollard, Y Ru, C Ritterson Lew, JE Duex, G Dancik, C Owens, ... Journal of the National Cancer Institute 106 (5), dju062, 2014 | 72 | 2014 |
Parameter estimation and sensitivity analysis in an agent-based model of Leishmania major infection GM Dancik, DE Jones, KS Dorman Journal of Theoretical Biology 262 (3), 398-412, 2010 | 57 | 2010 |
A tutor for counter-controlled loop concepts and its evaluation A Kumar, G Dancik 33rd Annual Frontiers in Education, 2003. FIE 2003. 1, T3C-7, 2003 | 55 | 2003 |
A cell of origin gene signature indicates human bladder cancer has distinct cellular progenitors GM Dancik, CR Owens, KA Iczkowski, D Theodorescu Stem cells 32 (4), 974-982, 2014 | 54 | 2014 |
Biomarkers for prognosis and treatment selection in advanced bladder cancer patients Y Ru, GM Dancik, D Theodorescu Current opinion in urology 21 (5), 420-427, 2011 | 53 | 2011 |
GON4L drives cancer growth through a YY1–androgen receptor–CD24 axis N Agarwal, GM Dancik, A Goodspeed, JC Costello, C Owens, JE Duex, ... Cancer research 76 (17), 5175-5185, 2016 | 47 | 2016 |
Transcriptional signatures of Ral GTPase are associated with aggressive clinicopathologic characteristics in human cancer SC Smith, AS Baras, CR Owens, G Dancik, D Theodorescu Cancer research 72 (14), 3480-3491, 2012 | 43 | 2012 |
Functional impact of chromatin remodeling gene mutations and predictive signature for therapeutic response in bladder cancer JE Duex, KE Swain, GM Dancik, RD Paucek, C Owens, MEA Churchill, ... Molecular Cancer Research 16 (1), 69-77, 2018 | 39 | 2018 |
Patient mutation directed shRNA screen uncovers novel bladder tumor growth suppressors J Hensel, JE Duex, C Owens, GM Dancik, MG Edwards, HF Frierson, ... Molecular Cancer Research 13 (9), 1306-1315, 2015 | 33 | 2015 |
Robust prognostic gene expression signatures in bladder cancer and lung adenocarcinoma depend on cell cycle related genes GM Dancik, D Theodorescu PloS one 9 (1), e85249, 2014 | 33 | 2014 |
A framework to select clinically relevant cancer cell lines for investigation by establishing their molecular similarity with primary human cancers GM Dancik, Y Ru, CR Owens, D Theodorescu Cancer research 71 (24), 7398-7409, 2011 | 30 | 2011 |
Nuclear CD24 drives tumor growth and is predictive of poor patient prognosis JE Duex, C Owens, A Chauca-Diaz, GM Dancik, LA Vanderlinden, ... Cancer research 77 (18), 4858-4867, 2017 | 29 | 2017 |
RhoC is an unexpected target of RhoGDI2 in prevention of lung colonization of bladder cancer EM Griner, GM Dancik, JC Costello, C Owens, S Guin, MG Edwards, ... Molecular Cancer Research 13 (3), 483-492, 2015 | 23 | 2015 |